TheraRadar
← Back
Data updated: Mar 29, 2026

THROMBOGENICS, INC

OphthalmologyMetabolic
Biotech

THROMBOGENICS, INC is a biotechnology company focused on Ophthalmology, Metabolic. Key products include JETREA.

2012
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

JETREA
ocriplasmin
· 2012

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Ophthalmology 75%
0 drugs Phase 2: 2 Phase 1: 2
Metabolic 25%
0 drugs Phase 1: 2

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

OTSUKA ICU MEDCL specialty
Metabolic, Ophthalmology
Bayer big-pharma
Ophthalmology, Metabolic
B BRAUN specialty
Ophthalmology, Metabolic
ASTELLAS specialty
Metabolic, Ophthalmology
UPJOHN big-pharma
Metabolic, Ophthalmology